Price $6.74 |
Market Cap
13M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
1.7
|
P/S
-
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
-4.9K
|
FCF
-
|
|
Op. Margin
-
|
Net Margin
-
|
ROE
-64.40%
|
ROI
-
|
|
ROA
-56.60%
|
EPS Growth
59.30%
|
Current Ratio
9.4
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Daxor Corporation (DXR) | $18.27 | - | - | 62.1M | Strong Buy |
| Pacific Biosciences of Califor (PACB) | $3.84 | - | - | 556.3M | Strong Buy |
| American Bio Medica Corporatio (ABMC) | $0.98 | - | - | 37.3M | Strong Buy |
| Acura Pharmaceuticals, Inc. (ACUR) | $0.35 | - | - | 7.5M | Strong Buy |
| Diversicare Healthcare Service (DVCR) | $1.67 | - | - | 11.3M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
